The Effect of Video-supported Education on Anxiety Levels and the ICU Experience

December 6, 2025 updated by: Zeynep Turak

The Effect of Video-supported Education About the Intensive Care Process on Anxiety Levels and the ICU Experience of Patients Scheduled for Open-heart Surgery

This study was conducted to examine the effects of video-assisted education about the intensive care process on intensive care experiences and anxiety levels of patients scheduled for open-heart surgery.

Research Hypotheses H01: Video-assisted education regarding the intensive care process provided to patients undergoing open heart surgery does not affect their experiences of intensive care.

H1: Video-assisted education regarding the intensive care process provided to patients undergoing open heart surgery does affect their experiences of intensive care.

H02: Video-assisted education regarding the intensive care process provided to patients undergoing open heart surgery does not affect patients' anxiety levels.

H2: Video-assisted education regarding the intensive care process provided to patients undergoing open heart surgery does affect patients' anxiety levels.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The study will include an experimental and a control group. Patients in the experimental group will be administered the Patient Introduction Form, Trait Anxiety and State Anxiety Scales 48 hours before surgery. Then, video-assisted training will be given about the intensive care process, and the state anxiety scale will be applied again 24 hours before the surgery. Twenty-four hours after discharge from the intensive care unit to the clinic, the State Anxiety Scale and Intensive Care Experience Scales will be applied again. These scales will also be applied to patients in the control group who did not receive video-assisted education. Control group patients will not receive any intervention other than standard nursing care.

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Yakutiye
      • Erzurum, Yakutiye, Turkey (Türkiye), 25240
        • Ataturk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients aged 18 and over,
  • Cognitively competent,
  • Communicative and cooperative,
  • Patients undergoing planned surgery (patients not admitted for emergency surgery),
  • Patients without a psychiatric diagnosis,
  • Patients with sensory impairments such as vision, hearing, or speech,
  • Patients with stable hemodynamic status in the clinic,
  • Patients who volunteered to participate in the study were included in the study.

Exclusion Criteria:

  • Patients who did not volunteer to participate,
  • Patients whose surgery was canceled,
  • Patients who underwent emergency surgery,
  • Patients who underwent combined bypass and valve surgery,
  • Patients with previous intensive care experience,
  • Patients who developed complications before, during, or after surgery were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Video training will be provided 48 hours before the surgery.
Other: Education with Video
Patients in the experimental group will be trained by the researcher 48 hours before the surgery with a video providing information about the intensive care process.
No Intervention: Control group
This group will receive no intervention other than the applied scales; only standard nursing care will be maintained.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intensive care experience
Time Frame: 24 hours after arriving from intensive care care
Intensive care experience will be evaluated with the Intensive Care Experience Scale. The scale has been developed to evaluate the experiences of patients in the intensive care unit.10 of the scale questions evaluate the frequency of the emotional condition in which the patient live, while the other 9 evaluate the compliance of the patient to intensive care. The substances prepared to evaluate the harmony of the patient in intensive care; Scored between 1 and 5.
24 hours after arriving from intensive care care
Anxiety level
Time Frame: 48 hours before surgery, 24 hours before surgery, 24 hours after intensive care unit
Anxiety level will be evaluated with the State-Trait Anxiety Inventory.The State-Trait Anxiety Inventory was first developed by Spielberger and colleagues in 1971, and its Turkish adaptation was completed by Öner and Le Compte in 1985. The scale consists of a total of 40 items and two separate subscales. The first 20 items assess individuals' state anxiety levels, while the remaining 20 items assess trait anxiety levels.
48 hours before surgery, 24 hours before surgery, 24 hours after intensive care unit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Zeynep Turak

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2023

Primary Completion (Actual)

January 30, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

April 10, 2024

First Submitted That Met QC Criteria

January 29, 2025

First Posted (Actual)

January 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 6, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B.30.2.ATA.0.01.00/363

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Open Heart Surgery

Clinical Trials on Education with Video

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe